NR1D2 and ovarian cancer: Considering the age of the patient at the initial pathologic diagnosis, 18 competing triplets are found to be associated with the overall survival time of patients in ovarian cancer, including miR-224-5p/AL354892.2/ZBTB12, miR-3653-3p/FGD5-AS1/NR1D2, miR-224-5p/AC112491.1/NDUFB8, and so on (Supplementary Table 2).